8-K: SiriusPoint Posts Strong Q3 Earnings, Boosted by Underwriting & MGA Sales

SiriusPoint Ltd. announced robust third-quarter 2025 results, featuring strong underwriting performance, significant premium growth, and strategic MGA disposals set to enhance shareholder value.

Summary

• SiriusPoint reported a Core combined ratio of 89.1% for Q3 2025, leading to an 11% increase in underwriting income to $70 million compared to the prior year.
• The company achieved an annualized operating return on equity of 17.9% in Q3 2025, exceeding its 12-15% across the cycle target range, and 16.1% year-to-date.
• Gross premiums written for the Core business grew by 26% in Q3 2025, marking the sixth consecutive quarter of double-digit growth, with Accident & Health being the largest contributor.
• Diluted earnings per common share were $0.73, and operating earnings per share increased by 41% to $0.72 compared to Q3 2024.
• Book value per diluted common share (excluding AOCI) rose by 5.3% in the quarter to $16.47, and by 12.5% year-to-date from December 31, 2024.
• The sale of two MGA investments, ArmadaCare and Arcadian, was announced, expected to unlock approximately $1.75 per share in value, which is not yet reflected in the current book value.
• S&P upgraded SiriusPoint's outlook to 'Positive' from 'Stable', marking the third upgrade in 2025.
• The company recorded no catastrophe losses in Q3 2025, contributing to improved underwriting results.
• Favorable prior year loss reserve development was $9.1 million in Q3 2025, marking the eighteenth consecutive quarter of such development.
• Net services fee income increased to $10.1 million in Q3 2025, up from $7.0 million in Q3 2024, with the service margin improving to 17.1% from 14.1%.

Sentiment

Score: 8

Explanation: The filing indicates strong financial performance across key metrics, including underwriting profitability, premium growth, and return on equity. Strategic MGA sales are set to further enhance shareholder value, and the positive outlook upgrade from S&P reinforces confidence. While there are some declines in investment income and higher year-to-date catastrophe losses, the overall picture is very positive, demonstrating effective execution of the company's strategy.

Positives

• Core combined ratio of 89.1% in Q3 2025 demonstrates strong underwriting performance.
• Underwriting income increased by 11% to $70 million in Q3 2025.
• Annualized operating return on equity of 17.9% in Q3 2025 and 16.1% year-to-date significantly exceeded the 12-15% target range.
• Gross premiums written for Core business grew by 26% in Q3 2025 and 16% year-to-date, indicating strong top-line growth.
• Operating diluted earnings per share increased by 41% to $0.72 in Q3 2025.
• Book value per diluted common share (ex. AOCI) increased by 5.3% in Q3 2025 to $16.47 and by 12.5% year-to-date.
• The BSCR estimate stands strong at 226% for Q3 2025.
• S&P upgraded the company's outlook to 'Positive' from 'Stable', reflecting improved financial strength.
• The announced sale of ArmadaCare and Arcadian MGAs is expected to unlock approximately $1.75 per share in value for shareholders.
• No catastrophe losses were incurred in Q3 2025, contributing to better underwriting results.
• Eighteen consecutive quarters of favorable prior year loss reserve development demonstrate reserving prudence.
• The company's combined ratio volatility is in the lowest quartile among peers, indicating stable performance.
• Over 90% of MGA premium mix comes from partners with 3+ year relationships, and over 70% of Q3 MGA growth came from these seasoned partners.
• Profit sharing is in place for 87% of MGA partners, aligning economic interests.
• The company maintains a disciplined approach, rejecting over 80% of MGA opportunities presented.

Negatives

• Net investment income decreased to $66.5 million in Q3 2025 from $77.7 million in Q3 2024, primarily due to a smaller asset base following capital transactions.
• Total investment result decreased to $72.7 million in Q3 2025 from $92.5 million in Q3 2024.
• Reinsurance gross premiums written decreased slightly by 1.6% to $309.6 million in Q3 2025 compared to Q3 2024.
• Catastrophe losses for the nine months ended September 30, 2025, were $67.4 million, significantly higher than $16.2 million for the same period in 2024, primarily due to California wildfires.
• Favorable prior year loss reserve development was lower in Q3 2025 ($9.1 million) compared to Q3 2024 ($29.7 million).
• The effective tax rate for the nine months ended September 30, 2025, increased primarily due to the new Bermuda corporate income tax.
• A loss on settlement and change in fair value of liability-classified capital instruments of $117.3 million was recorded in Q3 2025, impacting GAAP net income.

Risks

• Ability to execute on strategic transformation, including re-underwriting to reduce volatility, de-risking the investment portfolio, and transforming the business.
• Impact of unpredictable catastrophic events, including uncertainties with respect to losses from health pandemics, supply chain issues, labor shortages, changing interest rates, and equity market volatility.
• Inadequacy of loss and loss adjustment expense reserves.
• Lack of available capital, periods characterized by excess underwriting capacity, and unfavorable premium rates.
• Performance of financial markets, impact of inflation and interest rates, and foreign currency fluctuations.
• Ability to compete successfully in the insurance and reinsurance market and the effect of consolidation in the industry.
• Technology breaches or failures, including those resulting from malicious cyber-attacks.
• Effects of global climate change, including wildfires, increased severity and frequency of weather-related natural disasters, and increased coastal flooding.
• Geopolitical uncertainty, including ongoing conflicts in Europe and the Middle East and uncertainty from U.S. presidential administration policies.
• Global economic uncertainty caused by tariffs, inflation, trade wars, and potential impact on credit and mortgage business.
• Ability to retain key senior management and key employees.
• A downgrade or withdrawal of financial ratings.
• Fluctuations in results of operations.
• Legal restrictions on certain subsidiaries' ability to pay dividends and other distributions.
• Outcome of legal and regulatory proceedings and regulatory constraints on the business.
• Reduced returns or losses in the investment portfolio.
• Exposure or potential exposure to corporate income tax in Bermuda and the E.U., U.S. federal income and withholding taxes, and devaluation of deferred tax assets.
• Risks associated with delegating authority to third-party managing general agents.
• Future strategic transactions such as acquisitions, dispositions, investments, mergers, or joint ventures.

Future Outlook

SiriusPoint aims to build on its current progress and momentum, targeting a 12-15% return on equity across the cycle. The company expects to hit the upper end of its FY 2025 Net Investment Income guidance of $265 million to $275 million. Strategic MGA disposals are anticipated to unlock significant shareholder value, with proceeds targeted for the retirement of Series B preferred shares in February 2026, enhancing financial flexibility. The company continues to focus on profitable growth in low-volatility specialty lines and MGA partnerships.

Management Comments

• "The third quarter marked another successful quarter of delivery for SiriusPoint."
• "Strong underwriting performance, targeted growth, the announcement of two MGA disposals, and a positive outlook upgrade by S&P means there is a lot to be proud of."
• "We achieved a strong operating return on equity of 17.9% in the quarter, significantly ahead of our across the cycle 12-15% target range."
• "More importantly, our year to date operating return on equity of 16.1% is still outperforming our range despite heightened losses from the California Wildfires and aviation sector in the first half of the year."
• "Our third quarter Core combined ratio of 89.1% delivered an 11% increase in underwriting income compared to last year, aided in part by no catastrophe losses in the quarter."
• "We also continued to see strong top line growth with gross premiums written up 26% year over year for the quarter and 16% year to date, with Accident & Health being the most significant contributor."
• "We expect the previously announced sale of two of our MGA investments, ArmadaCare and Arcadian, to unlock significant value for shareholders representing an increase of around $1.75 per share, which is not yet included in our book value."
• "Our ambition remains unchanged: to build on the progress and momentum we have created. The third quarter marked another meaningful step forward on that journey."

Industry Context

SiriusPoint's strong Q3 2025 performance, characterized by robust underwriting profits and significant premium growth in specialty lines like Accident & Health and Surety, positions it favorably within the competitive insurance and reinsurance market. The focus on low-volatility business and strategic MGA partnerships aligns with broader industry trends towards specialized underwriting and efficient capital deployment. The S&P outlook upgrade further validates its strategic transformation efforts, distinguishing it from peers who may face higher volatility from catastrophic events.

Comparison to Industry Standards

• The annualized operating return on equity of 17.9% in Q3 2025 and 16.1% year-to-date significantly exceeds the company's own 'across the cycle' target range of 12-15%.
• SiriusPoint's combined ratio volatility is in the lowest quartile among a peer group including American Financial Group, AIG, Arch, AXIS, Chubb, Everest, Fidelis, Hamilton, James River, Markel, RenaissanceRe, RLI, Selective, Skyward Specialty, Travelers, and W.R. Berkley.
• The company has outperformed the peer average trailing twelve month Core combined ratio since Q4 2024, demonstrating superior underwriting discipline relative to competitors.

Stakeholder Impact

• Shareholders: Expected to benefit from increased book value per share, a declared dividend for preference shareholders, and potential future value creation from MGA disposals and strong operating performance.
• Employees: The company's ability to retain key senior management and employees is identified as a risk, suggesting their importance to ongoing success.
• Customers/Brokers: Continued provision of insurance and reinsurance solutions globally, with strengthened distribution capabilities through strategic partnerships.
• Creditors: Strong capital position (BSCR estimate at 226%) and a decreased leverage ratio indicate improved financial stability and ability to meet obligations.

Next Steps

• Hold a webcast on October 31, 2025, to discuss the third quarter 2025 results.
• Close the previously announced sale of ArmadaCare MGA investment in Q4 2025.
• Close the previously announced sale of Arcadian MGA investment in Q1 2026.
• Target the retirement of the Series B preferred issuance in February 2026.

Key Dates

Recommendation

SiriusPoint's Q3 2025 results demonstrate exceptional operational execution and strategic clarity. The company significantly exceeded its operating ROE targets, achieved robust premium growth, and maintained strong underwriting profitability with a low combined ratio volatility compared to peers. The announced MGA disposals are set to unlock substantial shareholder value, further strengthening the balance sheet and providing capital for future strategic moves, including the retirement of preference shares. The S&P outlook upgrade is a strong external validation. While investment income saw a slight decline due to asset base adjustments and year-to-date catastrophe losses were higher, the core business performance is outstanding and points to sustained positive momentum. This filing presents a compelling case for a 'strong buy' as the company continues its strategic transformation and value creation.

Keywords

Insurance, Reinsurance, Specialty Insurance, MGA, Underwriting, Financial Results, Q3 2025, SPNT, Bermuda, Property & Casualty, Accident & Health, Combined Ratio, Return on Equity, Gross Premiums Written